Skip to main content
TipRanks
Go Ultimate75% OFF

Livzon Pharmaceutical Group (LVZPF) Income Statement

5 Followers

Livzon Pharmaceutical Group Income Statement

Last quarter (Q3 2026), Livzon Pharmaceutical Group's total revenue was ¥2.32B, a decrease of 18.42% from the same quarter last year. In Q3, Livzon Pharmaceutical Group's net income was ¥355.85M. See Livzon Pharmaceutical Group’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
¥ 12.02B¥ 11.81B¥ 12.43B¥ 12.63B¥ 12.06B
¥ 7.92B¥ 7.73B¥ 7.66B¥ 8.17B¥ 7.81B
¥ 4.97B¥ 4.89B¥ 5.24B¥ 5.93B¥ 5.62B
Depreciation and Amortization¥ 539.01M¥ 575.14M¥ 840.32M¥ 652.32M¥ 445.27M
¥ 3.10B¥ 3.47B¥ 3.33B¥ 3.08B¥ 2.77B
¥ 2.95B¥ 2.84B¥ 2.42B¥ 2.35B¥ 2.27B
¥ -84.07M¥ -38.25M¥ -32.44M¥ -20.01M¥ -21.30M
¥ 2.86B¥ 2.81B¥ 2.38B¥ 2.33B¥ 2.25B
¥ 2.02B¥ 2.06B¥ 1.95B¥ 1.91B¥ 1.78B
Per Share Metrics
Basic EPS¥ 2.27¥ 2.24¥ 2.10¥ 2.04¥ 1.90
Diluted EPS¥ 2.27¥ 2.24¥ 2.10¥ 2.04¥ 1.90
Weighted Average Shares Outstanding893.10M920.13M930.31M933.86M934.46M
Weighted Average Shares Outstanding (Diluted)893.10M920.13M930.61M935.98M934.57M

Currency in CNY

Livzon Pharmaceutical Group Earnings and Revenue History

05B10B15B0 %20 %40 %60 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin